logo
  • Home
  • News
Menu

GC Pharma Announces GreenGene F Approval in China for the Treatment of Haemophilia A

Home / Stock Analysis / GC Pharma Announces GreenGene F Approval in China for the Treatment of Haemophilia A
Article feature image

GC Pharma Announces GreenGene F Approval in China for the Treatment of Haemophilia A

12 Aug Stock Analysis

YONGIN, South Korea–(BUSINESS WIRE)–GC Pharma (006280.KS) today announced the approval of GreenGene F (Beroctocog alfa)

Click here to view the original article.

Tags:
Business Wire, Global
Facebook Google+ Twitter Pinterest
  Previous
Next  

Related Posts

divis-labs-stock-price-today-live-03-dec-2025.jpg
+

Divis Labs Share Price Live Updates: Divis Labs maintains positive momentum

03 Dec Stock Analysis
hdfc-life-stock-price-today-live-03-dec-2025.jpg
+

HDFC Life Share Price Live Updates: HDFC Life’s three-month returns show a negative trend

03 Dec Stock Analysis

recent post

  • divis-labs-stock-price-today-live-03-dec-2025.jpg

    Divis Labs Share Price Live Updates:

    Dec 03 2025
  • 96405fbdaa4a4754a3d32528c0e4fe2f.jpeg

    EMJ’s Jackson aims to take volatility

    Dec 03 2025
  • hdfc-life-stock-price-today-live-03-dec-2025.jpg

    HDFC Life Share Price Live Updates:

    Dec 03 2025
  • 6ELBFFVRKNCKPABHPHRUUQY36E.png

    Crypto ETFs Saw Record Withdrawals as

    Dec 03 2025
  • kotak-bank-share-price-live-updates-03-dec-2025.jpg

    Kotak Bank Share Price Live Updates:

    Dec 03 2025

Categories

  • Business
  • Crypto News
  • Investing Strategy
  • People
  • Stock Analysis

©2019.  All Rights Reserved.